We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
426
Chipotle Mexican Grill
CMG
$40.7B
$36.6M 0.03%
1,319,150
-257,200
-16% -$7.68M
IWO icon
427
iShares Russell 2000 Growth ETF
IWO
$14.9B
$36.6M 0.03%
170,550
+16,188
+10% +$3.55M
AMCR icon
428
Amcor
AMCR
$21.8B
$36.3M 0.03%
609,136
+35,265
+6% +$2.06M
BSY icon
429
Bentley Systems
BSY
$10.7B
$36.2M 0.03%
979,855
+39,355
+4% +$1.43M
SRCL
430
DELISTED
Stericycle Inc
SRCL
$36.2M 0.03%
724,865
+42,242
+6% +$2.01M
ZBRA icon
431
Zebra Technologies
ZBRA
$17.9B
$36.1M 0.03%
140,953
+2,576
+2% +$666K
LRCX icon
432
Lam Research
LRCX
$383B
$35.9M 0.03%
853,010
-166,690
-16% -$6.97M
CDW icon
433
CDW
CDW
$17.1B
$35.8M 0.03%
200,565
+2,953
+1% +$519K
AZPN
434
DELISTED
Aspen Technology Inc
AZPN
$35.8M 0.03%
174,175
+5,826
+3% +$1.35M
MCO icon
435
Moody's
MCO
$82.8B
$35.7M 0.03%
128,242
+378
+0.3% +$103K
BN icon
436
Brookfield
BN
$109B
$35.7M 0.03%
1,702,463
-258,878
-13% -$5.8M
TDY icon
437
Teledyne Technologies
TDY
$32B
$35.7M 0.03%
89,208
+1,087
+1% +$423K
EFX icon
438
Equifax
EFX
$21.3B
$35.6M 0.03%
183,334
+6,377
+4% +$1.17M
FXN icon
439
First Trust Energy AlphaDEX Fund
FXN
$386M
$35.3M 0.03%
2,065,666
+218,019
+12% +$3.91M
ALLE icon
440
Allegion
ALLE
$14.1B
$35.1M 0.03%
333,810
+19,795
+6% +$2.06M
SPHD icon
441
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.39B
$34.9M 0.03%
796,776
+137,638
+21% +$5.91M
USFD icon
442
US Foods
USFD
$23.9B
$34.9M 0.03%
1,024,638
+146,654
+17% +$4.69M
STIP icon
443
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$34.8M 0.03%
358,845
-149,009
-29% -$14.5M
EIX icon
444
Edison International
EIX
$26.1B
$34.8M 0.03%
546,478
+137,850
+34% +$8.46M
VMC icon
445
Vulcan Materials
VMC
$37B
$34.7M 0.03%
198,333
+1,016
+0.5% +$174K
BABA icon
446
Alibaba
BABA
$317B
$34.6M 0.03%
392,679
-73,663
-16% -$5.81M
SITE icon
447
SiteOne Landscape Supply
SITE
$4.34B
$34.3M 0.03%
292,610
+5,155
+2% +$600K
IDA icon
448
Idacorp
IDA
$8.08B
$34.2M 0.03%
317,102
-18,950
-6% -$1.96M
GPN icon
449
Global Payments
GPN
$22.8B
$34.1M 0.03%
343,415
-52,127
-13% -$5.43M
DLB icon
450
Dolby
DLB
$5.82B
$34.1M 0.03%
482,715
+107,688
+29% +$7.42M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.